Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2003;52:163-164; doi:10.1136/gut.52.2.163
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2003;52:163-164
© 2003 by BMJ Publishing Group & British Society of Gastroenterology

COMMENTARY

Coeliac disease

Gastrointestinal intraepithelial lymphocytes and T cell lymphomas

I N Farstad1, K E A Lundin2

1 Institute of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway
2 Department of Medicine, University of Oslo, Rikshospitalet, Oslo, Norway

Correspondence to:
Correspondence to:
Dr I N Farstad, Institute of Pathology, Rikshospitalet, N-0027 Oslo, Norway;
i.n.farstad@labmed.uio.no


Enteropathy-type intestinal T cell lymphoma is assumed to derive from intraepithelial lymphocytes and recent reports describing an intermediate or "cryptic" stage of this lymphoma in patients with many characteristics of coeliac disease have challenged aspects of our understanding of coeliac disease and lymphoma development

Keywords: enteropathy-type intestinal T cell lymphoma; lymphocytic gastritis; lymphocytic colitis; coeliac disease; refractory sprue; T cell receptor gene rearrangement

The first 150 words of the full text of this article appear below.

Gastrointestinal T cell lymphomas occur less often than those of B cells but have a much more unfavourable prognosis.1 Enteropathy-associated T cell lymphoma (EATL) is the predominant subtype,1 "enteropathy" indicating a link to coeliac disease (CD).1 More recently, enteropathy-type intestinal T cell lymphoma (EITCL) seems to be the preferred term for this entity.2,3 EITCL is assumed to derive from intraepithelial lymphocytes (IELs) and recent reports describing an intermediate or "cryptic" stage of this lymphoma in patients with many characteristics of CD have provided a "missing link" in our understanding of the pathogenesis of EITCL.4,5

Refractory coeliac sprue (RCS) is diagnosed in patients with CD-like enteropathy who do not respond to a gluten free diet, primarily or some time after an initial response.6 RCS patients with phenotypically normal and polyclonal IELs may respond to immunosuppressive therapy.5 However, a large fraction of RCS patients have heavily increased IEL numbers lacking . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Refractory coeliac sprue is a diffuse gastrointestinal disease
V Verkarre, V Asnafi, T Lecomte, N Patey Mariaud-De Serre, M Leborgne, E Grosdidier, C Le Bihan, E Macintyre, C Cellier, N Cerf-Bensussan, and N Brousse
Gut 2003 52: 205-211. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs